Carl Griffin
Family Medicine · Oklahoma City, OKNPI 1003813825
Payments from drug & device makers
Across 3,231 payments — averaging $8729.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$17.5M
- Pfizer$2M
- Merck$1.3M
- Biogen$924K
- Bavarian Nordic A/s$834K
- Janssen Research & Development, LLC$756K
- plus $5M from 34 others
Across 9 payments — averaging $5301.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$34K
- Biogen$8K
- Pfizer$4K
- Eli Lilly$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$28,205,334 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Oklahoma City
- Alexander FrankOklahoma City$3.1M
- Charles LunnOklahoma City$1.4M
- Hieu NguyenOklahoma City$238K
- Melinda CailOklahoma City$122K
- Jose Maria Borrego AcostaOklahoma City$106K
- Brett CauthenOklahoma City$77K
- Angelique BarretoOklahoma City$74K
- John PittmanOklahoma City$39K
- Terrence TruongOklahoma City$32K
- Jonathon KnoxOklahoma City$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.